Clover Health Investments (BSP:CLOV34) Accounts Payable: R$181 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:CLOV34 Clover Health Investments Corp BSP:CLOV34
55 GF Score
Price R$21.55
GF Value R$23.14
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Clover Health Investments Accounts Payable?

Clover Health Investments BSP:CLOV34 55 Accounts Payable is R$181 Mil as of Jun. 2026. GuruFocus rates BSP:CLOV34 with a GF Score™ of 55/100 and a GF Value™ of R$23.14 (Fairly Valued). The stock has 2 warning signs investors should review.

Clover Health Investments's Accounts Payable for the quarter that ended in Jun. 2026 was R$181 Mil.

Clover Health Investments's quarterly Accounts Payable increased from Dec. 2025 (R$198 Mil) to Mar. 2026 (R$205 Mil) but then declined from Mar. 2026 (R$205 Mil) to Jun. 2026 (R$181 Mil).

Clover Health Investments's annual Accounts Payable increased from Dec. 2023 (R$182 Mil) to Dec. 2024 (R$211 Mil) but then declined from Dec. 2024 (R$211 Mil) to Dec. 2025 (R$198 Mil).

Clover Health Investments Accounts Payable Related Terms

Clover Health Investments Accounts Payable Historical Data

* Premium members only.

The historical data trend for Clover Health Investments's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clover Health Investments Accounts Payable Chart

Clover Health Investments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 159.07 170.19 182.19 210.88 197.56

Clover Health Investments Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 188.29 176.65 197.56 204.84 181.43
BSP:CLOV34
55GF Score
Clover Health Investments Corp BSP:CLOV34
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clover Health Investments Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of R$181 Mil mean?
Clover Health Investments (BSP:CLOV34) has a Accounts Payable of R$181 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Clover Health Investments and its competitors.
Is Clover Health Investments' Accounts Payable too high?
Clover Health Investments' current Accounts Payable is R$181 Mil. Overall, Clover Health Investments has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' Accounts Payable compare to PGNY and ALHC?
Clover Health Investments' Accounts Payable of R$181 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Healthcare Plans company?
A good Accounts Payable depends on the Healthcare Plans industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Clover Health Investments and its competitors. Clover Health Investments's current Accounts Payable is R$181 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (BSP:CLOV34) is currently considered Fairly Valued. The stock's GF Value™ is R$23.14, compared to a current price of R$21.55 — trading 6.9% below its estimated fair value. The current Accounts Payable is R$181 Mil. Clover Health Investments' overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Clover Health Investments (BSP:CLOV34), the current Accounts Payable is R$181 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clover Health Investments (BSP:CLOV34) Overvalued in 2026?

Based on GuruFocus' analysis, Clover Health Investments stock appears to be undervalued. The current stock price of R$21.55 is trading 6.9% below its estimated GF Value™ of R$23.14. GuruFocus considers Clover Health Investments to be Fairly Valued.

Key valuation signals for BSP:CLOV34:

  • Accounts Payable: R$181 Mil
  • GF Value™: R$23.14 vs. price of R$21.55 (6.9% below fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the BSP:CLOV34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clover Health Investments Business Description

Other Exchanges CLOV:USA7QD:Germany
Address 3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
55GF Score

Get the complete analysis for BSP:CLOV34

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$21.55
Price
R$23.14
GF Value